Products

BPC-157 is a synthetic peptide derived from human gastric juice. It comprises 15 amino acids and has a molecular weight of 1419.5355 Da. This peptide has been extensively researched for its potential therapeutic effects, particularly in promoting wound healing and tissue regeneration.

Key Mechanisms of Action 

• Angiogenesis Promotion: BPC-157 enhances the growth of new blood vessels, which is crucial for wound healing as it ensures adequate blood supply to support new tissue growth.
• Cell Proliferation and Migration: It stimulates the proliferation and migration of various cell types, including fibroblasts, which play a significant role in tissue regeneration.
• Anti-inflammatory Effects: BPC-157 reduces the production of pro-inflammatory cytokines while increasing anti-inflammatory cytokines, leading to a reduction in inflammation, pain, and swelling.
• Gastrointestinal Protection: It protects against damage caused by non-steroidal anti-inflammatory drugs (NSAIDs) by increasing the production of prostaglandins that maintain the integrity of the gastrointestinal lining.

Pharmacokinetics:

BPC-157 is stable in gastric juice, allowing for oral administration. It has a half-life of approximately 4-6 hours and is rapidly absorbed into the bloodstream. The peptide can also cross the blood-brain barrier, opening up possibilities for treating neurological disorders.

Therapeutic Applications:

• Wound Healing: Its ability to promote angiogenesis and tissue regeneration makes BPC-157 a potential treatment for chronic wounds, such as diabetic ulcers.

Uses for Cialis

Erectile Dysfunction

CIALIS^® is indicated for the treatment of erectile dysfunction (ED).

Benign Prostatic Hyperplasia

CIALIS is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).

Erectile Dysfunction And Benign Prostatic Hyperplasia

CIALIS is indicated for the treatment of ED and the signs and symptoms of BPH (ED/BPH).

Limitation Of Use

If CIALIS is used with finasteride to initiate BPH treatment, such use is recommended for up to 26 weeks because the incremental benefit of CIALIS decreases from 4 weeks until 26 weeks, and the incremental benefit of CIALIS beyond 26 weeks is unknown [see Clinical Studies] .

Dosage for Cialis

Do not split CIALIS tablets; entire dose should be taken.

CIALIS For Use As Needed For Erectile Dysfunction

• The recommended starting dose of CIALIS for use as needed in most patients is 10 mg, taken prior to anticipated sexual activity.
• The dose may be increased to 20 mg or decreased to 5 mg, based on individual efficacy and tolerability. The maximum recommended dosing frequency is once per day in most patients.
• CIALIS for use as needed was shown to improve erectile function compared to placebo up to 36 hours following dosing. Therefore, when advising patients on optimal use of CIALIS, this should be taken into consideration.

CIALIS For Once Daily Use For Erectile Dysfunction

• The recommended starting dose of CIALIS for once daily use is 2.5 mg, taken at approximately the same time every day, without regard to timing of sexual activity.
• The CIALIS dose for once daily use may be increased to 5 mg, based on individual efficacy and tolerability.

CIALIS For Once Daily Use For Benign Prostatic Hyperplasia

• The recommended dose of CIALIS for once daily use is 5 mg, taken at approximately the same time everyday.
• When therapy for BPH is initiated with CIALIS and finasteride, the recommended dose of CIALIS for once daily use is 5 mg, taken at approximately the same time every day for up to 26 weeks.

CIALIS For Once Daily Use For Erectile Dysfunction And Benign Prostatic Hyperplasia

The recommended dose of CIALIS for once daily use is 5 mg, taken at approximately the same time every day, without regard to timing of sexual activity.

Use With Food

CIALIS may be taken without regard to food.

Use In Specific Populations

Renal Impairment

CIALIS for Use as Needed

• Creatinine clearance 30 to 50 mL/min: A starting dose of 5 mg not more than once per day is recommended ,and the maximum dose is 10 mg not more than once in every 48 hours.
• Creatinine clearance less than 30 mL/min or on hemodialysis: The maximum dose is 5 mg not more than once in every 72 hours [see WARNINGS AND PRECAUTIONS and Use In Specific Populations].

CIALIS for Once Daily Use

Erectile Dysfunction

• Creatinine clearance less than 30 mL/min or on hemodialysis: CIALIS for once daily use is not recommended [see WARNINGS AND PRECAUTIONS and Use In Specific Populations] .

Benign Prostatic Hyperplasia And Erectile Dysfunction/Benign Prostatic Hyperplasia

• Creatinine clearance 30 to 50 mL/min: A starting dose of 2.5 mg is recommended. An increase to 5 mg maybe considered based on individual response.
• Creatinine clearance less than 30 mL/min or on hemodialysis: CIALIS for once daily use is not recommended [see WARNINGS AND PRECAUTIONS and Use In Specific Populations] .

Hepatic Impairment

CIALIS for Use as Needed

• Mild or moderate (Child Pugh Class A or B): The dose should not exceed 10 mg once per day. The use ofCIALIS once per day has not been extensively evaluated in patients with hepatic impairment and therefore, caution is advised.
• Severe (Child Pugh Class Cmax): The use of CIALIS is not recommended [see WARNINGS AND PRECAUTIONS and Use In Specific Populations] .

CIALIS for Once Daily Use

• Mild or moderate (Child Pugh Class A or B): CIALIS for once daily use has not been extensively evaluate din patients with hepatic impairment. Therefore, caution is advised if CIALIS for once daily use is prescribed to these patients.
• Severe (Child Pugh Class Cmax): The use of CIALIS is not recommended [see WARNINGS AND PRECAUTIONS and Use In Specific Populations] .

Concomitant Medications

Nitrates

Concomitant use of nitrates in any form is contraindicated [see CONTRAINDICATIONS] .

Alpha-Blockers

ED

When CIALIS is coadministered with an alpha-blocker in patients being treated for ED, patients should be stable on alpha-blocker therapy prior to initiating treatment, and CIALIS should be initiated at the lowest recommended dose [see WARNINGS AND PRECAUTIONS, DRUG INTERACTIONS and CLINICAL PHARMACOLOGY] .

BPH

CIALIS is not recommended for use in combination with alpha-blockers for the treatment of BPH [see WARNINGS AND PRECAUTIONS, DRUG INTERACTIONS and CLINICAL PHARMACOLOGY].

CYP3A4 Inhibitors

CIALIS for Use as Needed

For patients taking concomitant potent inhibitors of CYP3A4, such as ketoconazole or ritonavir, the maximum recommended dose of CIALIS is 10 mg, not to exceed once every 72hours [see WARNINGS AND PRECAUTIONS and DRUG INTERACTIONS] .

CIALIS for Once Daily Use

For patients taking concomitant potent inhibitors of CYP3A4, such as ketoconazole or ritonavir, the maximum recommended dose is 2.5 mg [see WARNINGS AND PRECAUTIONS and DRUG INTERACTIONS] .

Human Chorionic Gonadotropin (HCG) is a polypeptide hormone produced in both men and women. In women, it is produced in significant amounts during pregnancy, while in men, it is secreted in large quantities during puberty. HCG injections are used to stimulate the natural testosterone production system in men with low levels of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH).

The synthetic peptide version of the HCG hormone, Chorionic Gonadotropin Human peptide (hCG), plays crucial roles in maintaining pregnancy. It consists of two subunits, hCGα and hCGβ, which are glycosylated to produce various glycosylated hCG variants with distinct biological functions. The expression of genes encoding hCGα and hCGβ is regulated by hormones, growth factors, and cytokines. During early pregnancy, hCG is secreted by placental trophoblasts, with serum hCG levels peaking between gestational weeks 7 to 10. hCG has numerous roles in pregnancy, including stimulating progesterone production from the corpus luteum, promoting angiogenesis of uterine vasculature, and supporting the growth of fetal organs.

Mechanism of Action:

The use of HCG restores the natural function of the sex hormones LH and FSH, thereby enabling fertility in adults. HCG offers several remarkable benefits, including enhancing the physiological rhythm of testosterone production, maintaining normal testosterone levels, minimizing excess estradiol production, maintaining the normal size of testicles, stimulating sperm production, restoring the normal function of the testicles, and restoring the pituitary/hypothalamus axis.

IGF-1 LR3 allows for many of the growth-promoting effects of growth hormone insulin-like growth factors also know as IGF’s. IGF-1 LR3 comprises a family of peptides (protiens) that play important roles in mammalian growth and development. IGF1 LR3 is also known as Long R3 IGF-1 or Insulin-Like Growth Factor-I Long Arg3. The Long R3 IGF-1 version is significantly more potent than regular IGF-1. The enhanced potency is due to the decreased binding of IGF1 LR3 to all known IGF binding proteins. These binding proteins normally inhibit the biological actions of IGF’s therefore IG-1 LR3 has been shown to have increased efficacy and function . This IGF-1 LR3 analog of IGF-1 has been created with the purpose of increasing the biological activity of the IGF peptide. IGF1 LR3 is also known as Long R3 IGF-1 or Insulin-Like Growth Factor-I Long Arg3. This is a human recombinant, single, non-glycosylated, polypeptide chain containing 83 amino acids and having a molecular mass of 9200 Daltons. IGF1 mediates many of the growth-promoting effects of growth hormone (GH; MIM 139250). The LR3 is a long-term analog of human IGF-1, specifically designed and manufactured for mammalian cell culture to support large-scale manufacturing of recombinant biopharmaceuticals. Early studies showed that growth hormone did not directly stimulate the incorporation of sulfate into cartilage, but rather acted through a serum factor, termed ‘sulfation factor,’ which later became known as ‘somatomedin’. IGF-1 LR3 is the primary protein involved in responses of cells to growth hormone (GH): that is, IGF-I is produced in response to GH and then induces cellular activities. One such example is muscle growth or hyperplasia. This compound also makes the human body more sensitive to insulin. It is the most potent growth factor found in the human body. IGF-1 causes muscle cell hyperplasia, which is an actual splitting and forming of new muscle cells.

This formula has been chemically altered to avoid binding to proteins in the human body, and to increase the half life, approximately 20-30 hours.

IGF-1 LR3 allows us to go beyond our bodies genetic capabilities, by creating NEW muscle fibers (instead of just making them bigger) it gives us the ability to get stronger and performs better than normally. IGF-1 LR3 is the peptide specifically helpful in building muscle mass and strength. That is why many professionals use IGF-1 LR3 for high end performance benefits.

IGF-1 LR3 combats the loss of muscle mass, both by promoting new tissue growth and retarding apoptosis (cell suicide that protects against infection and healthy cells. It also promotes new nerve growth and has been linked to better cognitive performance.

Semaglutide is a medication that can aid in weight loss and improve blood sugar levels, potentially reducing the risk of cardiovascular events. It is a GLP-1 agonist, which means it works by increasing insulin release, decreasing glucagon levels, slowing down gastric emptying, and suppressing appetite. Additionally, semaglutide may offer other health benefits, such as improving blood pressure, cholesterol levels, and the function of beta-cells in the pancreas.

GLP-1 Agonists (Semaglutide):

GLP-1 agonists are a class of non-insulin drugs used alongside diet and exercise to manage type 2 diabetes. These medications help lower blood glucose levels and hemoglobin A1C while also aiding in weight loss. Semaglutide, a specific GLP-1 receptor agonist, has been shown to be effective in treating diabetes and obesity by enhancing insulin release, reducing glucagon levels, delaying gastric emptying, and curbing appetite. This results in better blood sugar control and weight loss.

Beyond blood sugar management, semaglutide has been linked to additional health benefits. Research indicates that it can improve beta-cell function in people with newly diagnosed type 2 diabetes. Moreover, semaglutide is associated with lower rates of major cardiovascular events, such as heart attacks and strokes, in individuals with type 2 diabetes and multiple cardiovascular risk factors.

Research on Semaglutide’s Efficacy:

A 2016 study published in the New England Journal of Medicine found that semaglutide led to significant weight loss and improved blood sugar control. Participants receiving semaglutide lost an average of 5% of their body weight over 68 weeks, compared to an average loss of 2% in the placebo group. Additionally, the semaglutide group experienced a lower rate of adverse cardiovascular events than the placebo group.

Mechanism of Action:

The exact mechanism of action of semaglutide is not fully understood, but it is believed to mimic the effects of GLP-1. Semaglutide binds to and activates the GLP-1 receptor, leading to increased insulin release from the pancreas. It also lowers glucagon levels and slows gastric emptying, which reduces appetite and aids in weight loss. Semaglutide may also improve beta-cell function, although the precise mechanism is not yet clear.

GLP-1 Agonists' Effects on Different Organs:

TB-500 is a synthetic form of Thymosin Beta-4, a 43-amino-acid protein that plays a crucial role in the regulation of actin polymerization. This protein is primarily utilized to enhance the healing of acute injuries that exhibit a slow recuperation rate. Additionally, TB-500 is administered post-heart attack to aid in the repair of damaged heart tissue through the activation of cardiac progenitor cells, which serve as a repair mechanism for the body.

Mechanism of Action and Doses

Thymosin Beta-4 is involved in the regulation of actin polymerization by encoding an actin-sequestering protein in eukaryotic cells. It is highly conserved in sequence and localized in tissues and circulating cells of the human body. Actin is a vital cell-building protein that plays significant roles in muscle contraction, cell division, cytokinesis, vesicle movement, and the maintenance of cell junctions and shape.

Thymosin is engaged in cell proliferation, migration, and differentiation due to its specific interaction with actin in the cell cytoskeleton, which provides the cell with shape and mechanical resistance to deformation. Additionally, Thymosin can enhance cellular respiration, enabling cells to gain useful energy to fuel cellular activities.

Scientifically Investigated Possible Benefits of TB-500:

Thymosin is known to increase the red blood cell count and oxygen delivery to muscles, resulting in improved energy utilization by the body. This helps reduce feelings of weakness and lethargy. The protein also promotes angiogenesis, the growth of new blood cells from existing vessels, which contributes to organism growth and wound healing. TB-500 accelerates injury repair, increases joint mobility, and encourages tissue repair, making it a sought-after treatment for high-performance athletes who wish to avoid prolonged recovery periods.